In a landmark discovery, scientists from the University of Cambridge and University College London have, for the first time, ...

AbbVie Inc. (NYSE:ABBV) ranks among the top picks for a retirement portfolio. The FDA received a New Drug Application from ...

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, announced the successful ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

Researchers at the University of Bath, in collaboration with the Universities of Oxford and Bristol, have developed a ...

In today’s Health Headlines, is every tremor an indicator of Parkinson’s disease, and common myths about medications for ...

A South Korean research group has reported in a new paper that artificial intelligence and light-based genetic tools can work together to diagnose and stop Parkinson’s-like disease in mice. The work ...

For treatment, the team used a new light-based therapy called optoRET. This method uses light to control brain signals and ...

Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more ...

Globally recognized figures Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease presents ...

AbbVie, which last year won FDA approval of its Vyalev subcutaneous 24-hour infusion therapy for Parkinson's, said a green light for tavapadon would bolster its position in the disease by providing ...

Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease ...